QA: Johnson Johnson in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2017_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 60,210,000,000
1 IntangibleAssetsNetIncludingGoodwill 47,393,000,000
2 PropertyPlantAndEquipmentNet 15,905,000,000
3 remainder_Assets 9,903,000,000
4 LiabilitiesCurrent 27,747,000,000
5 LiabilitiesNoncurrent 23,098,000,000
6 remainder_Liabilities 11,416,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,215,153,925
9 ResearchAndDevelopmentExpense 9,040,281,357
10 remainder_Expenses 26,655,831,171
11 remainder_Revenues 70,058,101,828
12 remainder_NetIncome 2,108,677,799
13 remainder_ComprehensiveNetIncome -3,486,319,251
  yvar yval
0 Assets 133,411,000,000
1 Liabilities 62,261,000,000
2 Expenses 56,911,266,453
3 Revenues 70,058,101,828
4 StockholdersEquity 71,150,000,000
5 NetIncome 15,255,513,174
6 ComprehensiveNetIncome 13,512,353,548
7 BaseVar 164,118,182,666
8 EconomicCapitalRatiobeforeLimitedLiability 1.72
9 EconomicCapitalRatio 2.84

Edgar->Model Mapping

Feature Distribution

Change over Time